Replies to post #817534 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Design aside, I’m surprised people are not thinking beyond day 1 if we moved to LSE. The multiple (valuation) increase possibilities are not as high but the stability is likely better. Trade off? One key would be strength and terms of any non-dilutive funding.